Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape.
Tyler N. Starr(University of Utah), Gyorgy Snell(VIR Biotechnology (United States))
Cited by 17
Related Papers
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
|Cell|2021|655
Deep mutational scans of XBB.1.5 and BQ.1.1 reveal ongoing epistatic drift during SARS-CoV-2 evolution
|PLoS Pathogens|2023|55
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape
|bioRxiv (Cold Spring Harbor Laboratory)|2021|21